REDUCING PATIENT ACCESSIBILITY BARRIERS IN THE CLINICAL SETTING AND THE VALUE OF LIVED EXPERIENCE
With
Hannah McPierzie, Disability Consultant & Advocate &
Chair, Deafblind West Australians &
Non-Executive Director, Deafness Forum Australia
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Perth | October 2025
Hannah McPierzie is a globally respected presenter, disability advocate, and educator who offers a unique perspective on disability and communication. She lives with Neurofibromatosis Type 2, a rare degenerative condition, and has two auditory brainstem implants. After 15 years teaching in the disability sector, Hannah acquired disability herself in 2020, when life-saving surgery left her deafblind.
Combining her professional expertise with lived experience, Hannah’s advocacy highlights the barriers people with disability face when navigating health systems, particularly in relation to communication access. She works with universities, hospitals, research institutes, private companies, and government agencies to build critical awareness of disability and to embed inclusive practices into policy and service design.
As Chairperson of Deafblind West Australians, Hannah has led initiatives that strengthen peer support and outreach for people with deafblindness. She is also a Non-Executive Director of Deafness Forum Australia, where she contributes to national advocacy on hearing loss. Her projects have included making advance care planning accessible for people with sensory loss, delivering community awareness training, and supporting the next generation of young leaders with disability.
Hannah is a keynote speaker at national and international conferences, where she champions the role of lived experience in health professions education and systemic reform. Her work consistently addresses the challenges of fragmented systems, inaccessible communication, and the need for genuine inclusion in decision-making. Based in Perth, Western Australia, Hannah continues to drive change that prioritises dignity, accessibility, and equity.
Source: Supplied
-
Clinical pain neuroscientist talks about how the brain processes pain information
Persistent pain affects one in five Australians and costs the nation an estimated $73 billion per year in health system costs, lost productivity and other financial costs.
Persistent pain also has debilitating personal costs – negatively impacting quality of life and the ability to engage in meaningful work and life activities.
Despite the enormity of this problem, very few effective treatments exist with most showing only small to moderate improvements. New treatments are desperately needed. The group believes the best way to create impactful change is to work with people with lived experience of persistent pain to devise solutions with them, not for them.
-
Misinformation impacts routine vaccines
More significant changes in recent years have been health-related misinformation eroding trust in healthcare professionals, leading to people seeking alternative treatments or avoiding medical advice altogether. This can make it more difficult for healthcare professionals to provide effective treatment and care.
Recent vaccines delivered as part of the COVID-19 response, are having a consequential impact on the uptake of routine vaccines.
Australian Health Journal spoke with Dr Paul Griffin, an Infectious Diseases Physician and Microbiologist at Mater Health, and who has been involved in over 150 clinical trials in the field of infectious disease.
Paul talks about the importance of having reputable sources of information that can used to encourage people to understand what is involved in clinical trials and the roles of vaccines.
-
Jack Lancaster, Evolution Surgical
Continuing the Australian Health Journal, People In Health Care series is Jack Lancaster, the CEO of Evolution Surgical, an Australian owned company established in 2014, specialising in spinal fusion implants and custom instrumentation.
Jack talks about how the company works closely with surgeons to design custom solutions manufactured to surgical requirements, and ultimately, to the benefit of the Australia patient.
